Abstract
Kallikreins are a subgroup of serine proteases with diverse physiological functions. The human kallikrein gene family has now been fully characterized and includes 15 members tandemly located on chromosome 19q13.4 In this review, we discuss the common structural features of kallikreins at the DNA, mRNA and protein levels and summarize their tissue expression and hormonal regulation. Kallikreins are expressed in a wide range of tissues including the salivary gland, endocrine tissues including testis, prostate, breast, endometrium, and the central nervous system. Most, if not all genes are under steroid hormone regulation. The classical kallikreins (KLK1-3) are thought to represent a distinct evolutionary subgroup of kallikreins. The occurrence of several splice variants is a very common phenomenon among kallikreins, and some of the splice variants appear to be tissue-specific and might be related to certain pathological conditions. We also provide a summary of predicted and experimentally confirmed promoter elements of kallikrein genes and describe repeat elements and polymorphisms within this genomic region.
Keywords: kallikreins, klk1, klk1-3, klk1-15
Current Genomics
Title: Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution
Volume: 4 Issue: 2
Author(s): George M. Yousef and Eleftherios P. Diamandis
Affiliation:
Keywords: kallikreins, klk1, klk1-3, klk1-15
Abstract: Kallikreins are a subgroup of serine proteases with diverse physiological functions. The human kallikrein gene family has now been fully characterized and includes 15 members tandemly located on chromosome 19q13.4 In this review, we discuss the common structural features of kallikreins at the DNA, mRNA and protein levels and summarize their tissue expression and hormonal regulation. Kallikreins are expressed in a wide range of tissues including the salivary gland, endocrine tissues including testis, prostate, breast, endometrium, and the central nervous system. Most, if not all genes are under steroid hormone regulation. The classical kallikreins (KLK1-3) are thought to represent a distinct evolutionary subgroup of kallikreins. The occurrence of several splice variants is a very common phenomenon among kallikreins, and some of the splice variants appear to be tissue-specific and might be related to certain pathological conditions. We also provide a summary of predicted and experimentally confirmed promoter elements of kallikrein genes and describe repeat elements and polymorphisms within this genomic region.
Export Options
About this article
Cite this article as:
Yousef M. George and Diamandis P. Eleftherios, Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution, Current Genomics 2003; 4 (2) . https://dx.doi.org/10.2174/1389202033350074
DOI https://dx.doi.org/10.2174/1389202033350074 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol’s Pharmacological Effects on Type I Endometrial Cancer
Anti-Cancer Agents in Medicinal Chemistry Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis
Current Drug Targets Editorial [Hot topic:Food Addiction & Obesity Treatment Development (Executive Guest Editors: Mark S. Gold and Noni A. Graham)]
Current Pharmaceutical Design Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents
Current Medicinal Chemistry Ruthenium Antimetastatic Agents
Current Topics in Medicinal Chemistry The Adenine Nucleotide Translocase 2, a Mitochondrial Target for Anticancer Biotherapy
Current Drug Targets Impact of Environmental Endocrine Disruption on the Reproductive System for Human Health
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Deregulation of HOX B13 Expression in Urinary Bladder Cancer Progression
Current Medicinal Chemistry Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry Angiogenesis-Related Cytokines in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Regulation of Gene Expression by Progesterone in Cancer Cells: Effects on Cyclin D1, EGFR and VEGF
Mini-Reviews in Medicinal Chemistry The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Meet the Editorial Board
Combinatorial Chemistry & High Throughput Screening RNAi in Clinical Studies
Current Medicinal Chemistry Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal Women
Current Pharmaceutical Design The Roles of Chromatin Remodeling Proteins in Cancer
Current Protein & Peptide Science The Genomics of Colorectal Cancer: State of the Art
Current Genomics